Prefer Newsweek on Google to see more of our trusted coverage when you search. New York Knicks guard Miles McBride's return to the court against the Oklahoma City Thunder didn’t go as planned on ...
If you watched the Brooklyn Nets' Wednesday-night matchup against the Oklahoma City Thunder, you may not be totally disappointed with the final product. A 29-point loss is abysmal, but the actual ...
Shares of CytomX Therapeutics surged after the company reported positive data from an expanded Phase 1 trial of a colorectal cancer treatment, despite swinging to a loss in 2025. Shares were up 60% to ...
Harry Hardwick told his supporters that no one needs to cry for him after March 14. Both of the Brit’s outings inside the Octagon have resulted in him suffering losses due to devastating injuries.
Lemonade (LMND) posted $17.6M in GAAP free cash flow for Q4, its first positive quarter since the 2020 IPO. Lemonade launched autonomous car insurance pricing Tesla FSD miles at 50% below human-driven ...
Wheels Up Experience Inc. (NYSE:UP) is one of the best penny stocks under $1 to buy right now. On February 19, Wheels Up Experience reported earnings for Q4 2025, achieving its first-ever positive ...
Researchers in Australia are raising flags about GLP-1 weight-loss medications potentially raising the risk of a rare disease. Scurvy — historically called a "pirate disease" due to long voyages at ...
LAKE COUNTY, Fla. - The morning sun is finally warming the fields at Southern Hill Farms, but for owners David and Lisa Hill, the thaw is revealing a several hundred thousand dollar loss. After a ...
Roche obesity drug shows 22.5% weight loss in Phase-II trial Roche focuses on catching Lilly in $150 billion obesity market Investors lukewarm on CT-388 results in crowded market The company said on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results